Last edition
News about Market
A large-scale study involving more than 6,800 lymphoma patients found that CAR T-cell therapy delivered at non-FACT accredited centres achieved outcomes comparable to accredited facilities, supporting efforts to expand access to advanced cancer treatments closer to patients’ homes.
Market | 30/05/2026 | By News Bureau
SK Bioscience’s partnership with VECOL positions SK bioscience as a strategic technology transfer partner in Colombia’s national vaccine self-sufficiency initiative, supporting local manufacturing, public health preparedness and regional supply resilience.
Market | 28/05/2026 | By News Bureau
Asahi Kasei Life Science Acquires License for Novel ADC Technology from The Noguchi Institute
Asahi Kasei Life Science Secures Rights to Novel Antibody Drug Conjugate (ADC) Technology from The Noguchi Institute to Advance Safer and More Efficient Cancer Therapies
Market | 28/05/2026 | By News Bureau
NunaBio Raises Euro 6.5 Million to Scale Next-Generation DNA Manufacturing Platform
NunaBio’s latest funding to accelerate DNA micro-foundry development, expand manufacturing capabilities and strengthen infrastructure for synthetic biology, therapeutics, and research applications.
Market | 21/05/2026 | By News Bureau
Hansa Biopharma Signs IDEFIRIX Licensing Deal with SERB Pharmaceuticals for Europe and MENA
Hansa Biopharma signs a €115 million licensing agreement with SERB Pharmaceuticals for commercialisation of IDEFIRIX across Europe and MENA, strengthening its financial position ahead of a potential US launch.
Market | 21/05/2026 | By News Bureau
Samsung Bioepis Launches First Biosimilar Product in Japan with Ustekinumab Therapy
Samsung Bioepis launches its ustekinumab biosimilar in Japan through a partnership with Nipro Corporation, expanding access to affordable treatments for chronic autoimmune diseases.
Market | 21/05/2026 | By News Bureau
Dr. Reddy's Launches Oral Semaglutide Biosimilar Obeda Tablets in India
Dr. Reddy's launches Obeda oral semaglutide tablets in India, strengthening its GLP-1 portfolio after recent generic semaglutide injection launches in India and Canada for diabetes and obesity care.
Market | 20/05/2026 | By News Bureau | 172
InMed Pharmaceuticals and Mentari Therapeutics Mergers to Advance Next-Generation Migraine Therapies
InMed Pharmaceuticals and Mentari Therapeutics have entered into a definitive merger agreement, combining Mentari’s migraine-focused drug pipeline with InMed’s public market infrastructure to support the development of innovative therapies targeting chronic and episodic migraine.
Market | 20/05/2026 | By News Bureau | 147
Zydus Lifesciences Completes Investment in Torrent Urja 25 with Rs 90.18 Million Share Subscription
Zydus Lifesciences and its subsidiaries have completed the final tranche of investment in Torrent Urja 25, subscribing to equity shares worth Rs 90.18 million and concluding the transaction initiated under the Share Subscription and Shareholders’ Agreements (SSSAs).
Market | 20/05/2026 | By News Bureau | 142
Indian Pharmacist Association Distances Itself From Proposed Nationwide Pharmacy Strike
Indian Pharmacist Association has announced that it will not support the nationwide pharmacy strike called by All India Organisation of Chemists and Druggists, joining several state-level trade and pharmacist bodies that have rejected the bandh.
Market | 19/05/2026 | By News Bureau | 161
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy